82 related articles for article (PubMed ID: 19026486)
1. Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.
Zhao Y; Planas-Silva MD
Cancer Lett; 2009 Mar; 275(2):204-12. PubMed ID: 19026486
[TBL] [Abstract][Full Text] [Related]
2. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
Fan P; Wang J; Santen RJ; Yue W
Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
[TBL] [Abstract][Full Text] [Related]
4. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.
Hiscox S; Jiang WG; Obermeier K; Taylor K; Morgan L; Burmi R; Barrow D; Nicholson RI
Int J Cancer; 2006 Jan; 118(2):290-301. PubMed ID: 16080193
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.
Lin CY; Lin CJ; Chen KH; Wu JC; Huang SH; Wang SM
FEBS Lett; 2006 May; 580(13):3042-50. PubMed ID: 16678166
[TBL] [Abstract][Full Text] [Related]
8. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
[TBL] [Abstract][Full Text] [Related]
9. Targeting c-Src kinase enhances tamoxifen's inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins.
Planas-Silva MD; Hamilton KN
Cancer Chemother Pharmacol; 2007 Sep; 60(4):535-43. PubMed ID: 17186241
[TBL] [Abstract][Full Text] [Related]
10. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer.
Planas-Silva MD; Bruggeman RD; Grenko RT; Stanley Smith J
Biochem Biophys Res Commun; 2006 Mar; 341(1):73-81. PubMed ID: 16412380
[TBL] [Abstract][Full Text] [Related]
11. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
12. An acidic extracellular pH induces Src kinase-dependent loss of beta-catenin from the adherens junction.
Chen KH; Tung PY; Wu JC; Chen Y; Chen PC; Huang SH; Wang SM
Cancer Lett; 2008 Aug; 267(1):37-48. PubMed ID: 18423982
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.
Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G
Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation and cadherin/catenin function.
Daniel JM; Reynolds AB
Bioessays; 1997 Oct; 19(10):883-91. PubMed ID: 9363682
[TBL] [Abstract][Full Text] [Related]
15. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin.
Lilien J; Balsamo J
Curr Opin Cell Biol; 2005 Oct; 17(5):459-65. PubMed ID: 16099633
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
Kurokawa H; Arteaga CL
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4436s-4442s; discussion 4411s-4412s. PubMed ID: 11916237
[TBL] [Abstract][Full Text] [Related]
17. The E-cadherin complex contains the src substrate p120.
Aghib DF; McCrea PD
Exp Cell Res; 1995 May; 218(1):359-69. PubMed ID: 7537697
[TBL] [Abstract][Full Text] [Related]
18. Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis.
Rengifo-Cam W; Konishi A; Morishita N; Matsuoka H; Yamori T; Nada S; Okada M
Oncogene; 2004 Jan; 23(1):289-97. PubMed ID: 14712234
[TBL] [Abstract][Full Text] [Related]
19. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
20. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G
J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
